🔗 Permalink

Inventor profile of:

Sei Ryang Oh

City:

Daejeon

Country:

South Korea

Published Applications:

Last publication date:

2025-05-22

Top Assignees for applications by Sei Ryang Oh

The entities that hold a legal rights for patent applications filed by inventor Oh Sei Ryang:

KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY 34 Daejeon, South Korea
YUNGJIN PHARMACEUTICAL CO., LTD. 6 Seoul, South Korea
KOREA RESEARCH INSTITUTE OF BIO SCIENCE AND BIOTECHNOLOGY 3 Daejeon, South Korea
ENZYCHEM LIFESCIENCES CORPORATION 3 Daejeon, South Korea
Enzychem Lifesciences Corporation 2 Seoul, South Korea
Dongguk University Industry-Academic Cooperation Foundation 2 Seoul, South Korea
Enzychem Lifesciences Corporation 2 Englewood Cliffs, NJ United States
ENZYCHEM LIFESCIENCES CORPORATION 1 Yuseong-Gu, Daejeon, South Korea
SEOUL NATIONAL UNIVERSITY HOSPITAL 1 Seoul, South Korea
Korea Institute of Bioscience and Biotechnology 1 , South Korea
Research Business Foundation SungKyunKwan University 1 Suwon-si, South Korea
Korea Research Institute of Bioscience and Biotechnology 1 , South Korea
KOREA INSTITUTE OF ORIENTAL MEDICINE 1 Daejeon, South Korea
Korea Research Institute of Bioscience and Biotechnology 1 Daejon, South Korea
KOREA RESEARCH INSTITUTE OF BIONSCIENCE AND BIOTECHNOLOGY 1 Yuseong-Gu, Daejeon, South Korea
RESEARCH BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY 1 Suwon-si, Gyeonggi-do, South Korea
KOREA RESEARCHINSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY 1 Daejeon, South Korea

Recent patent applications by Oh Sei Ryang

Sei Ryang Oh from Daejeon, KR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-05-22

US20250161340A1

Human necessities

COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING DRY EYE SYNDROME OR MEIBOMIAN GLAND DYSFUNCTION

#2 | 2024-08-08

US20240261356A1

Human necessities

COMPOSITION CONTAINING ACANTHOPANAX EXTRACT AND GARCINIA CAMBOGIA EXTRACT OR COMPOUND ISOLATED THEREFROM AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF LIVER DISEASE

#3 | 2024-08-01

US20240254155A1

Chemistry; metallurgy

NOVEL COMPOUND ISOLATED FROM SPINACH, AND COMPOSITION COMPRISING SAME FOR PREVENTING OR TREATING INFLAMMATORY DISEASES

#4 | 2023-11-16

US20230364170A1

Human necessities

COMPOSITION FOR PREVENTING OR TREATING OBESITY OR DIABETES, COMPRISING ACANTHOPANAX SENTICOSUS EXTRACT AND GARCINIA CAMBOGIA EXTRACT OR COMPOUND ISOLATED THEREFROM

#5 | 2023-05-11

US20230144344A1

Human necessities

COMPOSITION FOR PREVENTING OR TREATING CARDIOVASCULAR AND METABOLIC DISEASES COMPRISING ELAEOCARPUS PETIOLATUS

#6 | 2022-05-19

US20220151979A1

Human necessities

COMPOSITION FOR PREVENTION OR TREATMENT OF CARDIOVASCULAR AND METABOLIC DISEASE COMPRISING NORANHYDROICARITIN

#7 | 2021-02-25

US20210052536A1

Human necessities

COMPOSITION CONTAINING MONOACETYLDIGLYCERIDE COMPOUND AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE

#8 | 2020-10-22

US20200330421A1

Human necessities

COMPOSITION CONTAINING MONOACETYLDIACYLGLYCEROL COMPOUND AS ACTIVE INGREDIENT FOR INHIBITING BLOOD CANCER OR METASTASIS

#9 | 2019-01-24

US20190022047A1

Human necessities

Composition containing monoacetyldiacylglycerol compound as active ingredient for inhibiting blood cancer or metastasis

#10 | 2019-01-10

US20190008820A1

Human necessities

Composition containing monoacetyldiacylglycerol compound as active ingredient for preventing or treating asthma

#11 | 2018-12-13

US20180353561A1

Human necessities

Pharmaceutical composition for preventing and treating chronic obstructive lung disease containing, as active ingredient, extract, fraction, or active fraction thereof

#12 | 2018-10-04

US20180280336A1

Human necessities

Composition containing monoacetyldiglyceride compound as active ingredient for preventing or treating chronic obstructive pulmonary disease

#13 | 2018-05-10

US20180125903A1

Human necessities

Method for treating neuroinflammation with a pharmaceutical composition containing hook. extract or fraction thereof as active ingredient

#14 | 2018-04-19

US20180105548A1

Chemistry; metallurgy

A novel compound (KS-513) isolated from Pseudolysimachion rotundum var. subintegrum, the composition comprising the same preventing or treating allergic disease, inflammatory disease, asthma or chronic obstructive pulmonary disease and the use thereof

#15 | 2017-09-21

US20170266142A1

Human necessities

Method of treating chronic obstructive pulmonary disease (CPD) with verproside

#16 | 2017-08-03

US20170217982A1

Chemistry; metallurgy

Compound isolated from Pseudolysimachion rotundum var. subintegrum, the composition comprising the same for treating allergic disease, inflammatory disease, asthma or chronic obstructive pulmonary disease and the use thereof

#17 | 2017-06-22

US20170174645A1

Chemistry; metallurgy

2-phenylbenzofuran derivatives, method for preparing the same and use of the same for treating inflammatory disease

#18 | 2017-06-22

US20170173095A1

Human necessities

Pharmaceutical composition for preventing or treating asthma comprising J. Poiss. ex Franch extract or fraction thereof

#19 | 2017-06-22

US20170173065A1

Human necessities

Antiviral composition containing material involved in phosphatidylcholine synthesis pathway

#20 | 2017-02-23

US20170049838A1

Human necessities

Method of treating inflammation, allergy and asthma with a purified extract (ATC1) isolated from var. containing abundant amount of active ingredient

#21 | 2017-02-23

US20170049837A1

Human necessities

Method of treating inflammation, allergy and asthma with a purified extract (ATC2) isolated from var. containing abundant amount of active ingredient

#22 | 2017-02-16

US20170042854A1

Human necessities

COMPOSITION CONTAINING MONOACETYLDIGLYCERIDE COMPOUND AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASES

#23 | 2017-02-09

US20170035822A1

Human necessities

Pharmaceutical composition comprising extract, fraction of same or compound separated from same for preventing or treating chronic obstructive pulmonary disease (COPD)

#24 | 2017-02-02

US20170028010A1

Human necessities

Purified extract (ATC1) isolated from var. subintegrum containing abundant amount of active ingredient, the preparation thereof, and the composition comprising the same as an active ingredient for preventing or treating inflammation, allergy and asthma

#25 | 2016-11-17

US20160332980A1

Chemistry; metallurgy

NOVEL 2-PHENYLBENZOFURAN DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PRODUCTION METHOD FOR SAME AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASE COMPRISING SAME AS ACTIVE INGREDIENT

#26 | 2016-09-29

US20160279088A1

Human necessities

COMPOSITION FOR PROMOTING DIFFERENTIATION OR PROLIFERATION OF ERYTHROCYTIC CELLS, CONTAINING MONOACETYL DIACYLGLYCEROL COMPOUND AS ACTIVE INGREDIENT

#27 | 2016-09-08

US20160256428A1

Human necessities

Composition containing monoacetyldiacylglycerol compound as active ingredient for inhibiting blood cancer or metastasis

#28 | 2016-08-11

US20160228402A1

Human necessities

Composition containing lignan compound as active ingredient for preventing or treating cancer

#29 | 2016-07-14

US20160199430A1

Human necessities

Purified extract (ATC2) isolated from var. containing abundant amount of active ingredient, the preparation thereof, and the composition comprising the same as an active ingredient for preventing or treating inflammation, allergy and asthma

#30 | 2016-07-14

US20160199339A1

Human necessities

Composition containing monoacetyldiacylglycerol compound as active ingredient for preventing or treating asthma

#31 | 2016-07-14

US20160199338A1

Human necessities

COMPOSITIONS CONTAINING MONOACETYLDIACYLGLYCEROL COMPOUND AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING RHEUMATOID ARTHRITIS

#32 | 2016-07-07

US20160193174A1

Human necessities

Composition containing monoacetyldiglyceride compound as active ingredient for preventing or treating atopic dermatitis

#33 | 2016-06-16

US20160166528A1

Human necessities

Compositions containing monoacetyldiacylglycerol compound as an active ingredient for preventing or treating rheumatoid arthritis

#34 | 2016-02-25

US20160051612A1

Human necessities

Composition comprising a purified extract isolated from var. containing abundant amount of active ingredient or the compounds isolated therefrom, as an active ingredient for treating a chronic obstructive pulmonary disease and the use thereof

#35 | 2015-04-02

US20150093456A1

Human necessities

Pharmaceutical composition for treating wounds or revitalizing skin comprising extracts, fractions thereof or diterpene compounds separated from the fractions as active ingredient

#36 | 2014-12-18

US20140371311A1

Chemistry; metallurgy

Ingenane-type diterpene compound, and pharmaceutical composition for treating or preventing viral infectious diseases containing same

#37 | 2014-12-18

US20140370126A1

Human necessities

Pharmaceutical composition for preventing or treating inflammatory diseases or asthma, containing lagerstroemia ovalifolia extract or fraction thereof as active ingredient

#38 | 2014-12-11

US20140364492A1

Chemistry; metallurgy

Phorbol type diterpene compound, pharmaceutical composition for treatment or prevention of viral infectious diseases including same

#39 | 2014-08-14

US20140228427A1

Human necessities

PHARMACEUTICAL COMPOSITION CONTAINING WOGONIN AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING ASTHMA

#40 | 2014-03-13

US20140072664A1

Chemistry; metallurgy

Daphne genkwa extracts, and pharmaceutical composition containing fractions of the extracts or compounds separated from the extracts as active ingredients for preventing or treating atopic dermatitis

#41 | 2013-12-05

US20130323331A1

Human necessities

Pharmaceutical composition for the prevention and treatment of inflammatory disease or asthma containing an extract of

#42 | 2013-09-19

US20130244959A1

Human necessities

Composition containing styraxlignolide A or the aglycone thereof as an active ingredient for preventing or treating asthma

#43 | 2013-06-27

US20130164395A1

Human necessities

Pharmaceutical composition for preventing or treating inflammatory diseases, allergic diseases or asthma, containing A. DC. extract as active ingredient

#44 | 2013-05-02

US20130108652A1

Human necessities

Asthma diagnosis using the neuropilin-1 gene, and method for screening for a therapeutic agent for asthma

#45 | 2012-12-06

US20120308676A1

Human necessities

Antiviral composition containing an or extract or a fraction thereof as an active ingredient

#46 | 2012-07-19

US20120184499A1

Human necessities

Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity

#47 | 2012-07-19

US20120183632A1

Human necessities

Pharmaceutical composition comprising an extract of and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity

#48 | 2010-04-01

US20100081638A1

Human necessities

Compositions comprising an extract of or compounds isolated therefrom for preventing and treating cancer diseases

#49 | 2009-12-31

US20090324750A1

Human necessities

Pharmaceutical composition comprising an extract of and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity

#50 | 2009-06-11

US20090148542A1

Chemistry; metallurgy

Composition comprising an extract of and tiarellic acid isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity

#51 | 2008-04-03

US20080081081A1

Human necessities

extract and composition containing tilianin isolated and purified from said extract having anti-inflammatory activity and anti-atherogenic activity

#52 | 2007-03-22

US20070066577A1

Human necessities

BENZOXAZOLE DERIVATIVE OR ANALOGUE THEREOF FOR INHIBITING 5-LIPOXYGENASE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

InventorID:

222014 ⎘